
NYSEHealthcareMedical - Instruments & Supplies
Latest quote
$124.19
−$0.29 · -0.23%
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Latest quote
$124.19
−$0.29 · -0.23%
After-hours
$124.19
$0.00 · 0.00%
Oct 8, 4:27 PM ET
Regular session · ET · Market data may be delayed.
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Day range
Current $124.19
52-week range
Current $124.19
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
54
Fair Value
Sentiment
68
Bullish
Risk
24
Moderate Risk
Momentum
50
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Day range
Current $124.19
52-week range
Current $124.19
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.99B USD | 3.05B USD | 2.97B USD | 2.79B USD | 2.81B USD |
| Cost of goods sold | 871.96M USD | 1.34B USD | 1.33B USD | 1.26B USD | 1.26B USD |
| Gross profit | 1.12B USD | 1.7B USD | 1.65B USD | 1.53B USD | 1.55B USD |
| Research and development | 144.78M USD | 161.67M USD | 154.35M USD | 153.82M USD | 130.84M USD |
| Selling, general, and administrative | 720.17M USD | 995.27M USD | 929.87M USD | 863.75M USD | 860.09M USD |
| Operating expenses | 864.95M USD | 1.55B USD | 1.14B USD | 1.03B USD | 921.51M USD |
| Interest income | 6.4M USD | 8.01M USD | 12.78M USD | 912K USD | 1.33M USD |
| Interest expense | 100.22M USD | 83.54M USD | 85.08M USD | 54.26M USD | 56.97M USD |
| Depreciation and amortization | 177.74M USD | 274.6M USD | 242.12M USD | 230.59M USD | 237.36M USD |
| Operating income | 255.8M USD | 151.01M USD | 506.31M USD | 499.73M USD | 628.1M USD |
| Net income | −905.64M USD | 69.68M USD | 356.33M USD | 363.14M USD | 485.37M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Cash distributions grouped by calendar year; partial years are marked.
$1.36
2025 complete year0.0% since 2021
2026 partial: $1.02
$1.36
2,021
$1.36
2,022
$1.36
2,023
$1.36
2,024
$1.36
2,025
$1.02
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 14, 2026 | $0.34Quarterly | Aug 14, 2026 | Sep 30, 2026 |
Dividend | May 22, 2026 | $0.34Quarterly | May 25, 2026 | Jun 30, 2026 |
Dividend | Mar 6, 2026 | $0.34Quarterly | Mar 6, 2026 | Mar 31, 2026 |
Dividend | Nov 14, 2025 | $0.34Quarterly | Nov 14, 2025 | Dec 15, 2025 |
Dividend | Aug 15, 2025 | $0.34Quarterly | Aug 15, 2025 | Sep 15, 2025 |
Dividend | May 20, 2025 | $0.34Quarterly | May 20, 2025 | Jun 16, 2025 |
Ex-dividend Aug 14, 2026
$0.34
Quarterly
Record Aug 14, 2026 · Payment Sep 30, 2026
Ex-dividend May 22, 2026
$0.34
Quarterly
Record May 25, 2026 · Payment Jun 30, 2026
Ex-dividend Mar 6, 2026
$0.34
Quarterly
Record Mar 6, 2026 · Payment Mar 31, 2026
Ex-dividend Nov 14, 2025
$0.34
Quarterly
Record Nov 14, 2025 · Payment Dec 15, 2025
Ex-dividend Aug 15, 2025
$0.34
Quarterly
Record Aug 15, 2025 · Payment Sep 15, 2025
Ex-dividend May 20, 2025
$0.34
Quarterly
Record May 20, 2025 · Payment Jun 16, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core S&P Small-Cap ETFIJR315.28M0.31%104.29B USD0.06%$137.31+0.17%
Vanguard Morningstar Total Stock Market ETFVTI199.88M0.01%2.3T USD0.03%$379.56-0.39%
Vanguard Morningstar Small-Cap ETFVB144.66M0.08%185.3B USD0.03%$287.63+0.23%
Vanguard Morningstar Small-Cap Value ETFVBR91.89M0.13%68.2B USD0.05%$233.91+0.75%
Vanguard Extended Market ETFVXF73.08M0.08%95.4B USD0.05%$233.13-0.15%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM49.01M0.31%16.01B USD0.03%$53.36+0.15%
iShares S&P Small-Cap 600 Value ETFIJS43.71M0.58%7.63B USD0.18%$129.59+0.44%
Dimensional - US Small Cap ETFDFAS42.98M0.13%33.66B USD0.31%$78.10+0.23%
iShares Core S&P Small-Cap ETFIJR
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
Vanguard Extended Market ETFVXF
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
iShares S&P Small-Cap 600 Value ETFIJS
Dimensional - US Small Cap ETFDFASAI-generated and delayed market data for informational and educational purposes only. Not investment advice.